Strategic Research Institute Release: Pharma & Biotech Licensing Deal-Making Summit In La Jolla, CA Attracts Top Business Development Executives From Around The Industry For March 27-29 Annual Conference

LA JOLLA, Calif., Feb. 28 /PRNewswire/ -- The world's Pharmaceutical and Biotech business development communities, CEOs/CSOs, and investors are all slated to gather in La Jolla, CA in March to attend sessions and search for new partnering opportunities at the 11th annual meeting, featuring hundreds of high-level attendees, reports Strategic Research Institute. The yearly meeting is a hotbed of networking and information in response to increasing numbers of business development deals that characterize the pharmaceutical business.

The 2006 meetings keynote speakers are: Deal-Making Trends, Lisa Ricciardi, Senior Vice President, Licensing & Development, Pfizer, Inc. Big Pharma: Is it Possible for Large Companies to Continue to Grow?, Stefan Loren, Ph.D., Vice President, MTB Investment Advisors Establishing Partnerships for Building A Worldwide Collaboration in Combination Therapies, Jung E. Choi, Senior Director, Corporate Development, GileadSciences Building a Global Infectious Disease Franchise Through Licensing and Other Business Development Activities, Anthony Rosenberg, Global Head of Business Development & Licensing, Novartis Pharma AG Licensing Growth through Partnership Creativity and Flexibility, Joshua M. Salisbury, Vice President, Corporate Business Development, Eli Lilly and Company Asia Pacific Deal-Making: Partnering Perspectives from Japan, Korea, Singapore, ANZ & Korea, James Foley, Ph.D., Vice President Business Development, Japan, Bristol-Myers Squibb Company Pharma and Biotech Partnering - The VC View , Pratik Shah, Ph.D., Venture Partner, Thomas, McNerney & Partners

In addition to the keynotes, many other speakers are featured from firms such as Genzyme, Merck, Indevus, Sanofi-Aventis, Roche, Schering Plough, Celgene, Abgenix, MedImmune, BiogenIDEC, Amylin, Ligand, Bristol-Myers Squibb, TAP, AstraZeneca, and GlaxoSmithKline.

The information and networking extravaganza is punctuated by receptions and other nightly socializing functions, plus for the first time in the series history, a partnering fair and one-on-one networking. Lead sponsors are Campbell Alliance and RCP Diagnostics LLC.

To request the agenda and/or the preliminary list of attendees, contact the organizer, Mark Alexay of Strategic Research Institute, at malexay@srinstitute.com or at 212.967.0095, extension 251. All executive level Pharma, biotech, diagnostics, technology, medical device, and investor personnel are encouraged to attend.

CONTACT: Mark Alexay of Strategic Research Institute,malexay@srinstitute.com, or +1-212-967-0095, ext. 251

Web site: http://www.srinstitute.com/